Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.69 CAD | -1.43% | -2.82% | +62.35% |
Apr. 17 | Treatment.com AI Inc. Announces New Additions to Its Medical Education Suite | CI |
Apr. 10 | Treatment.com AI Partnering With aiXplain Inc. to Extend Access to its Global Library of Medicine | MT |
Valuation
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Capitalization 1 | 54.24 | 3.312 |
Enterprise Value (EV) 1 | 53.32 | 3.876 |
P/E ratio | -3.84 x | -0.87 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | -36,433,806 x | -24,975,231 x |
FCF Yield | -0% | -0% |
Price to Book | 494 x | -1.51 x |
Nbr of stocks (in thousands) | 6,615 | 6,624 |
Reference price 2 | 8.200 | 0.5000 |
Announcement Date | 5/2/22 | 5/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -0.0965 | -0.0701 | -0.6724 | -2.908 | -13.9 | -3.787 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.0956 | -0.0739 | -0.7619 | -2.908 | -13.86 | -3.797 |
Net income 1 | -0.0956 | -0.0739 | -0.7619 | -2.908 | -13.86 | -3.797 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.0457 | -0.0349 | -0.2376 | -0.5088 | -2.138 | -0.5736 |
Free Cash Flow | - | -0.0764 | -0.2701 | -0.9216 | -1.464 | -0.1552 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/25/21 | 1/25/21 | 1/25/21 | 4/30/21 | 5/2/22 | 5/1/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 0.56 |
Net Cash position 1 | 0.01 | 0.03 | 0.52 | 0.31 | 0.92 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | -0.08 | -0.27 | -0.92 | -1.46 | -0.16 |
ROE (net income / shareholders' equity) | - | 553% | -423% | -6,697% | 18,080% | 365% |
ROA (Net income/ Total Assets) | - | -118% | -145% | -439% | -1,383% | -495% |
Assets 1 | - | 0.0629 | 0.5248 | 0.6629 | 1.002 | 0.7669 |
Book Value Per Share 2 | -0.0200 | 0 | 0.0600 | -0.0400 | 0.0200 | -0.3300 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.1000 | 0.0500 | 0.1400 | 0 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 1/25/21 | 1/25/21 | 1/25/21 | 4/30/21 | 5/2/22 | 5/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+62.35% | 19.77M | |
+4.36% | 32.47B | |
+14.14% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.15B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- TRUE Stock
- Financials Treatment.com AI Inc.